Clinical Research
A modified method of platelet-rich plasma preparation and level measurement of growth factors
Xue Chenhong, Huang Zhizhen, Peng Fen, Chen Zhou, Zhang Jianzhong
Published 2021-12-15
Cite as Chin J Med Aesth & Cosmet, 2021, 27(6): 531-534. DOI: 10.3760/cma.j.issn.1671-0290.2021.06.020
Abstract
ObjectiveTo establish a safe, effective, simple, and more economically feasible method to obtain platelet-rich plasma (PRP).
MethodsWhole blood was collected from 24 patients with atrophic acne scars on the face. For the preparation of PRP, a slight modification of Choukroun's method was used. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of platelet derived growth factor-β(PDGF-β), transforming growth factor-β1 (TGF-β1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), isulin-like growth factor-1 (IGF-1) in normal plasma and PRP.
ResultsThe average concentration of PDGF-β in PRP was (755.61±418.31) ng/L, which was higher than [(479.93±279.18) ng/L] in normal plasma (t=3.479, P<0.01). The average concentration of TGF-β1 in PRP was (2267.00±1223.68), which was higher than [(1535.50±910.91) ng/L] in normal plasma (t=7.082, P<0.01). The average concentration of EGF in PRP was (30.70±12.39) ng/L, which was higher than [(20.77±10.31) ng/L] in normal plasma (t=6.899, P<0.01). The average concentration of VEGF in PRP was (25.42±17.69) ng/L, which was higher than [(12.01±7.77) ng/L] in normal plasma (t=5.230, P<0.01). The average concentration of bFGF was (17.85±7.17) ng/L, which was higher than [(10.90±4.73) ng/L] in normal plasma (t=6.050, P<0.01). The average concentration of IGF-1 was (201.22±36.80) ng/ml, which was higher than [(174.90±33.80) ng/ml] in normal plasma (t=3.760, P<0.01).
ConclusionsCompared to normal plasma, modified PRP contains higher levels of growth factors. The modified method is a reliable option for liquid PRP, especially applicable for invasive cosmetic laser surgery to promote wound repair.
Key words:
Platelet-rich plasma; Modification method; Platelet-rich plasma; Growth factors; Enzyme-linked immunosorbent assay; Concentration
Contributor Information
Xue Chenhong
Department of Dermatology, Peking University People's Hospital, Beijing 100044, China
Huang Zhizhen
Department of Dermatology, Chang Geng Hospital, Xiamen 361028, China
Peng Fen
Department of Dermatology, Peking University People's Hospital, Beijing 100044, China
Chen Zhou
Department of Dermatology, Peking University People's Hospital, Beijing 100044, China
Zhang Jianzhong
Department of Dermatology, Peking University People's Hospital, Beijing 100044, China